Evidence map›Paper›PMID 30655371›Full record

ArticleHaematologica2019

A confirmation of chronic graft-

Jed Paul, Hideki Nakasone, Bita Sahaf, Fang Wu, Kathy Wang, Vincent Ho, Juan Wu, Haesook Kim, Bruce Blazar, Jerome Ritz and 3 more

Abstract readLetterMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Neoself Antigens Presented on MHC Class II Molecules in Autoimmune Diseases.Advances in experimental medicine and biology · 2024
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jed PaulDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Hideki NakasoneDivision of Hematology, Saitama Medical Center, Jichi Medicial University, Saitama, Japan.
Bita SahafDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Fang WuDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Kathy WangDivision of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Vincent HoDivision of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Juan WuThe Emmes Corporation, Rockville, MD, USA.
Haesook KimDivision of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Bruce BlazarDivision of Pediatrics BMT, Minneapolis, MN, USA.
Jerome RitzDivision of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Alan HowardCenter for International Blood and Marrow Transplant Research, Minneapolis Campus, Minneapolis, MN, USA.
Corey CutlerDivision of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
David MiklosDivision of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA dmiklos@stanford.edu.

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
Transgenic/KnockoutP01AI056299 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SHARPE, ARLENE H. · 2003 to 2023
$42.5M
Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host DiseaseP01CA142106 · NCI · DANA-FARBER CANCER INST · PI CUTLER, COREY S · 2009 to 2019
$17.5M
Manipulation of Immune Responsiveness after Hematopoietic Cell TransplantationR01CA183559 · NCI · DANA-FARBER CANCER INST · PI RITZ, JEROME, SOIFFER, ROBERT JON · 2013 to 2017
$3.7M
Reconstitution of Regulatory T Cells After Stem Cell TransplantationR01CA183560 · NCI · DANA-FARBER CANCER INST · PI RITZ, JEROME, SOIFFER, ROBERT JON · 2013 to 2017
$2.5M
BMT CTN Core - University of MinnesotaUG1HL069290 · NHLBI · UNIVERSITY OF MINNESOTA · PI Mark Juckett, Margaret L MacMillan · 2017 to 2026
$1.9M
NCI NIH HHS P01 CA142106NCI NIH HHS R01 CA183559NCI NIH HHS R01 CA183560NCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U24 HL138660NHLBI NIH HHS UG1 HL069290NIAID NIH HHS P01 AI056299
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedChildChild, PreschoolFemaleFollow-Up StudiesGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansIsoantibodiesMaleMiddle AgedPrognosisRetrospective StudiesH-Y antibodyIsoantibodies

Identifiers

PMID30655371
PMCPMC6601098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.